European guidelines for personality disorders: past, present and future

Sebastian Simonsen1, Anthony Bateman2, Martin Bohus3,4, Henk Jan Dalewijk5, Stephan Doering6, Andres Kaera7, Paul Moran8, Babette Renneberg9, Joaquim Soler10, Svenja Taubner11, Theresa Wilberg12, Lars Mehlum13
1Stolpegaard Psychotherapy Centre, Copenhagen, Denmark
2University College, London and Anna Freud National Centre for Children and Families, University of Copenhagen, London, UK
3Institute of Psychiatric and Psychosomatic Psychotherapy
4Central Institute of Mental Health, Heidelberg University, Mannheim, Germany
5Private practice, Weesp, The Netherlands
6Department of Psychoanalysis and Psychotherapy, Medical University of Vienna, Vienna, Austria
7Kanta-Häme Central Hospital, Hämeenlinna, Finland
8Centre for Academic Mental Health, Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
9Freie Universität, Berlin, Germany
10Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
11Universitätsklinikum Heidelberg | Universität Heidelberg, Heidelberg, Germany
12Department of Research and Development, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
13National Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Tóm tắt

Từ khóa


Tài liệu tham khảo

Fok ML-Y, et al. Life expectancy at birth and all-cause mortality among people with personality disorder. J Psychosom Res. 2012;73(2):104–7.

Cramer V, Torgersen S, Kringlen E. Personality disorders and quality of life. A population study. Compr Psychiatry. 2006;47(3):178–84.

Field M, Lohr K. Institute of Medicine Committee to advise the public Health service on clinical practice guidelines. In: Clinical practice guidelines: directions for a new program. Washington, DC: National Academy Press; 1990.

Woolf SH, et al. Potential benefits, limitations, and harms of clinical guidelines. Bmj. 1999;318(7182):527–30.

Woolf S, et al. Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations. Implement Sci. 2012;7(1):61.

Brouwers MC, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839–42.

McDonald CJ, Overhage JM. Guidelines you can follow and can trust: an ideal and an example. Jama. 1994;271(11):872–3.

Grol R, et al. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. Bmj. 1998;317(7162):858–61.

Ekselius L, et al. Personlighetssyndrom, kiniska riktlinjer för utredning och behandling. 2017: Gothia Förlag AB.

Excellence, N.I.f.H.a.C., Borderline personality disorder: treatment and management (CG78). 2009.

Health, N. and M.R. Council, Clinical practice guideline for the management of borderline personality disorder. 2012, National Health and Medical Research Council Melbourne.

Association, F.M.S.D.a.t.F.P., Epävakaa persoonallisuus. Käypä hoito -suositus. [Borderline Personality Disorder. Current Care Guidelines]. 2015.

Qaseem A, et al. Guidelines international Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7):525–31.

Vind, AB, et al. National klinisk retningslinje for behandling af emotionel ustabil personlighedsstruktur, borderline type. 2015.

DGPPN - Deutsche Gesellschaft für Psychiatrie, P.u.N.H., Behandlungsleitlinie Persönlichkeitsstörungen. Reihe: S2 Praxisleitlinien in Psychiatrie und Psychotherapie, Band 1. 2009.

Muche-Borowski C, et al. Das AWMF-Regelwerk Leitlinien: Ständige Kommission “Leitlinien” der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). 2012.

Committee DPMG. Dutch multidisciplinary guideline for personality disorders. Utrecht: Trimbos-institute; 2008.

Instituut, T, Zorgstandaard persoonlijkheidsstoornissen: Kwaliteitsontwikkeling GGZ [Care standard personality disorders: Quality development mental health care]. 2017.

Excellence, N.I.f.H.a.C., Antisocial personality disorder:prevention and management (Clinica guideline CG77). 2009.

Omar H, Tejerina-Arreal M, Crawford MJ. Are recommendations for psychological treatment of borderline personality disorder in current UK guidelines justified? Systematic review and subgroup analysis. Personal Ment Health. 2014;8(3):228–37.

Euler S, et al. Borderline-Störung: Behandlungsempfehlungen der SGPP. Psychiatr Psychother. 2018;169(5):135–43.

Network, S.I.G., R.T. Harbour, and L. Forsyth, SIGN 50: a guideline developer's handbook. 2008: Scottish Intercollegiate Guidelines Network.

Bamelis LL, et al. Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders. Am J Psychiatr. 2014;171(3):305–22.

Weinbrecht A, et al. Avoidant personality disorder: a current review. Curr Psychiatry Rep. 2016;18(3):29.

Cristea IA, et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(4):319–28.

Association, A.P., Practice guideline for the treatment of patients with borderline personality disorder. 2001: American Psychiatric Pub.

Stoffers-Winterling JM, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012(8):1-255.

Mehlum L. DBT as a Suicide and Self-harm Treatment: Assessing and Treating Suicidal Behaviours. The Oxford handbook of dialectical behaviour therapy. Oxford: Oxford University Press; 2018.

McHugh RK, Barlow DH. The dissemination and implementation of evidence-based psychological treatments: a review of current efforts. Am Psychol. 2010;65(2):73.

Tmej A, et al. Changes in attachment representation in psychotherapy: is reflective functioning the crucial factor? Z Psychosom Med Psychother. 2018;64(3):222–36.

Moran P, et al. The influence of personality disorder on the future mental health and social adjustment of young adults: a population-based, longitudinal cohort study. Lancet Psychiatry. 2016;3(7):636–45.

Choi-Kain LW, Albert EB, Gunderson JG. Evidence-based treatments for borderline personality disorder: implementation, integration, and stepped care. Harvard Review of Psychiatry. 2016;24(5):342–56.

Stoffers J, et al. Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev, 2010(6):1-324.